ភាគហ៊ុនថែទាំសុខភាពនេះធ្លាក់ចុះ 30% នៅថ្ងៃសុក្រ៖ ពន្យល់នៅទីនេះ

Tenet Healthcare Corp (NYSE: THC) crashed a 52-week low on Friday after reporting a weak Q3 and lowering its outlook for the full financial year.

Tenet to buyback shares

On the plus side, the healthcare services company announced a $1.0 billion share repurchase programme. In the សេចក្តីប្រកាសព័ត៌មានស្តីពីប្រាក់ចំណូល, CEO Saum Sutaria said:

តើអ្នកកំពុងស្វែងរកព័ត៌មានរហ័សព័ត៌មានជំនួយក្តៅនិងការវិភាគទីផ្សារមែនទេ? ចុះឈ្មោះសម្រាប់ព្រឹត្តិប័ត្រ Invezz ថ្ងៃនេះ។

Our business continues to generate strong free cash flow, enabling us to authorise a share repurchase programme that balances our uses of capital with investments to grow the business and debt retirement.

But investors seem to have discounted that authorisation.

The sell-off, though, might have created an attractive opportunity to វិនិយោគលើភាគហ៊ុននេះ។ considering the Wall Street has a consensus “buy” rating on it. The average price target on Tenet Healthcare Corp is $92 that represents more than a 100% upside from here.

Tenet Healthcare Q3 results

• រកបាន 131 លានដុល្លារធៀបនឹងឆ្នាំមុន 449 លានដុល្លារ
• ប្រាក់ចំណូលក្នុងមួយហ៊ុនបានធ្លាក់ចុះយ៉ាងខ្លាំងពី 4.13 ដុល្លារទៅ 1.16 ដុល្លារ
• On an adjusted basis, earned $1.44 per share
• ប្រាក់ចំណូលបានធ្លាក់ចុះ 2.0% ពីមួយឆ្នាំទៅមួយឆ្នាំ មកត្រឹម 4.80 ពាន់លានដុល្លារ
• ការយល់ស្របគឺ $ 1.24 ក្នុងមួយហ៊ុនលើប្រាក់ចំណូល $ 4.81 ពាន់លានដុល្លារ

Tenet Healthcare future outlook

For the full year, Tenet now forecasts $5.88 to $6.42 of adjusted EPS on $19 billion to $19.2 billion in revenue. In comparisons, analysts had called for $6.38 a share and $19.27 billion of revenue.

Its Q4 guidance was also below the Street expectations. CEO Sutaria also said:

During Q3, we worked to continue to recover from our cyberattack and dealt with a very active COVID spike among our employees, but the operating discipline across our business units allowed us to adapt to the environment.